about
Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settingsRandomized trial of time-limited interruptions of protease inhibitor-based antiretroviral therapy (ART) vs. continuous therapy for HIV-1 infectionCharacterizing breast conditions at an open-access breast clinic in South Africa: a model that is more than cancer care for a resource-limited settingComparisons of anemia, thrombocytopenia, and neutropenia at initiation of HIV antiretroviral therapy in Africa, Asia, and the Americas.Atypical squamous cells, cannot exclude high grade squamous intraepithelial (ASC-H) in HIV-positive women.Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa.Fear of Treatments Surpasses Demographic and Socioeconomic Factors in Affecting Patients With Breast Cancer in Urban South AfricaIncidence and progression of cervical lesions in women with HIV: a systematic global review.Diverse and high prevalence of human papillomavirus associated with a significant high rate of cervical dysplasia in human immunodeficiency virus-infected women in Johannesburg, South Africa.Association between HIV replication and serum leptin levels: an observational study of a cohort of HIV-1-infected South African womenThe prevalence of hepatitis B co-infection in a South African urban government HIV clinic.Occult hepatitis B virus infection in patients with isolated core antibody and HIV co-infection in an urban clinic in Johannesburg, South AfricaValidation of cervical cancer screening methods in HIV positive women from Johannesburg South AfricaEvaluation of a cervicography-based program to ensure quality of visual inspection of the cervix in HIV-infected women in Johannesburg, South AfricaImmunogenicity and safety of the quadrivalent human papillomavirus vaccine in HIV-1-infected women.Cost evaluation of reproductive and primary health care mobile service delivery for women in two rural districts in South Africa.Metabolic and anthropometric parameters contribute to ART-mediated CD4+ T cell recovery in HIV-1-infected individuals: an observational studyCost-effectiveness of using the Cervex-Brush (broom) compared to the elongated spatula for collection of conventional cervical cytology samples within a high-burden HIV setting: a model-based analysis.A Randomized Comparison of Anthropomorphic Changes With Preferred and Alternative Efavirenz-Based Antiretroviral Regimens in Diverse Multinational SettingsProspective One Year Follow Up of HIV Infected Women Screened for Cervical Cancer Using Visual Inspection with Acetic Acid, Cytology and Human Papillomavirus Testing in Johannesburg South AfricaEffect of trichomoniasis therapy on genital HIV viral burden among African womenDifferences in antiretroviral safety and efficacy by sex in a multinational randomized clinical trialSevere adverse events during second-line tuberculosis treatment in the context of high HIV Co-infection in South Africa: a retrospective cohort studyHighly active antiretroviral therapy and cervical dysplasia in HIV-positive women in South Africa.Antiretroviral therapy interruptions result in loss of protective humoral immunity to neoantigens in HIV-infected individuals.Evaluation of Xpert MTB/RIF Versus AFB Smear and Culture to Identify Pulmonary Tuberculosis in Patients With Suspected Tuberculosis From Low and Higher Prevalence SettingsPharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342).High-risk oncogenic HPV genotype infection associates with increased immune activation and T cell exhaustion in ART-suppressed HIV-1-infected womenInjectable and oral contraception and the incidence and progression of cervical disease in HIV-infected women in South Africa.Evaluation of two line probe assays for rapid detection of Mycobacterium tuberculosis, tuberculosis (TB) drug resistance, and non-TB Mycobacteria in HIV-infected individuals with suspected TB.Human papillomavirus vaccines: where do they fit in HIV-infected individuals?Cervical cancer risk and impact of Pap-based screening in HIV-positive women on antiretroviral therapy in Johannesburg, South Africa.A randomized clinical trial comparing cervical dysplasia treatment with cryotherapy vs loop electrosurgical excision procedure in HIV-seropositive women from Johannesburg, South Africa.Cryotherapy reduces progression of cervical intraepithelial neoplasia grade 1 in South African HIV-infected women: a randomized, controlled trial.Impact of Larger Sputum Volume on Xpert® MTB/RIF Assay Detection of Mycobacterium tuberculosis in Smear-Negative Individuals with Suspected Tuberculosis.Herpes Simplex Virus Type 2 Acquisition Among HIV-1-Infected Adults Treated With Tenofovir Disoproxyl Fumarate as Part of Combination Antiretroviral Therapy: Results From the ACTG A5175 PEARLS Study.Performance of the Cellslide® automated liquid-based cytology system amongst HIV-positive womenComplex regional pain syndrome in a HIV seropositive patient starting antiretroviral therapy.Bacterial vaginosis as a risk factor for high-grade cervical lesions and cancer in HIV-seropositive women.HPV vaccination in Southern Africa: A jab of hope in the fight against cervical cancer.
P50
Q21144607-FEF9E33C-3FDF-495B-9CAE-B66F7C8565BAQ28478848-1E9FC4C1-1148-4C2F-A231-A66293DEBCB7Q30490752-5E6470CD-2F5A-42B4-99F0-BD02AECD9BAAQ33392372-CE6FA031-5BFF-4BEF-A588-B9468A9CF114Q33626438-7D9D86E9-0F10-46ED-973B-7E5D5F481DEBQ33716047-A359E3A3-CA8F-49ED-9A69-90305956A62EQ33859766-25705ADA-E40D-4CA7-97D9-C26ED90D6797Q33924965-395CE62B-562C-4D36-99B8-8069351ED046Q34070356-BE80147E-8F41-4145-841A-063397F3BD7BQ34138834-F9AA251E-D416-42EA-A8BE-1D2D96A023EEQ34432918-B28B4BC1-4D17-48CC-BB95-0C860A7B74D9Q34468872-38DB275D-2A18-4C9D-899A-64CACA155EB6Q34551436-B5AD6078-29E0-4EC0-88EC-F6B0AF55179EQ34743814-D2B6B834-435F-406B-955E-E1B711F83FF4Q35008398-A7B55910-9D14-41B7-B658-8EB009D47247Q35159171-D82E32B4-CD38-4163-B4E2-81295583D68CQ35185674-CE3B6B20-FAE8-4F23-8D8C-B5BFF2090DDAQ35834645-10BD820A-CED3-430B-AEAF-31325397F0E4Q35881469-2145D521-3AA4-4590-8592-1B3EEE3EB4EEQ35885106-28040EDD-23B0-472B-B61F-DFB972544EBAQ36099364-95F01ED9-634D-4783-9C63-24010765AEBEQ36157703-111B5045-9EA3-410B-84CC-BD3A0E54E645Q36171130-4ADBF2CB-04DD-43B0-B3A5-1FB7E510A655Q36404058-0CC09D2D-604D-4E17-8125-F6E1BCC335B4Q36544183-B64CD3AF-0B9D-4244-A09D-71260A7426D7Q36783193-C6460C5E-BCFA-4D31-ABBC-33BAFF3FDECBQ36901492-6C3945BE-6C1B-41AB-9C49-A394B8D0DE32Q37012660-00AFC491-C0B7-4CCC-A198-B518DC55864EQ37678594-27FE9FA9-2296-4581-8F99-D7DA0E0B862DQ37713474-8BAAEBF0-E62E-49C3-B2FD-6C863C6571B0Q38022478-2F339812-1F31-4E14-9162-9304AB42ADD6Q38821448-0220D8E4-09DB-4F98-AAB3-420EF40BBF84Q38861795-88FA7BF9-6C05-46A0-8702-7756A99A61F3Q40043858-D4D846E1-5BF0-4793-8D94-156132D85F77Q40104129-216486BA-3988-4540-96A2-564EFBA5EA97Q40223007-A60F979E-8D10-4C2B-B58E-83C276174C32Q40940849-A911297B-D532-4946-8F03-BB265EDF5D0AQ43222192-9B7F252B-44D2-4A16-93C0-C9D6634E39A8Q44186976-366734C0-3184-43CB-A40A-E400803C33A1Q46146633-65BBCCDA-A9EF-4EA7-B908-6DBDE0FE5991
P50
name
Cynthia Firnhaber
@en
Cynthia Firnhaber
@nl
type
label
Cynthia Firnhaber
@en
Cynthia Firnhaber
@nl
prefLabel
Cynthia Firnhaber
@en
Cynthia Firnhaber
@nl